Michael M Woll
Overview
Explore the profile of Michael M Woll including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
104
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Woll M, Maerz L
Anesthesiol Clin
. 2016 Nov;
34(4):669-680.
PMID: 27816127
The elderly population is rapidly increasing in number. Therefore, geriatric trauma is becoming more prevalent. All practitioners caring for geriatric trauma patients should be familiar with the structural and functional...
2.
Gates J, Carmichael M, Benavides L, Holmes J, Hueman M, Woll M, et al.
J Am Coll Surg
. 2009 Feb;
208(2):193-201.
PMID: 19228530
Background: E75 is an immunogenic peptide from the HER2/neu protein that is expressed in prostate cancer. High-risk prostate cancer (HRPC) patients demonstrating varying levels of HER2/neu expression were vaccinated with...
3.
Peoples G, Holmes J, Hueman M, Mittendorf E, Amin A, Khoo S, et al.
Clin Cancer Res
. 2008 Feb;
14(3):797-803.
PMID: 18245541
Purpose: E75 is an immunogenic peptide from the HER2/neu protein, which is overexpressed in many breast cancer patients. We have conducted two overlapping E75 vaccine trials to prevent recurrence in...
4.
Hueman M, Dehqanzada Z, Novak T, Gurney J, Woll M, Ryan G, et al.
Clin Cancer Res
. 2005 Oct;
11(20):7470-9.
PMID: 16243821
Purpose: The E75 peptide is an immunogenic peptide from the HER-2/neu protein that is substantially expressed in prostate cancer. We are conducting a clinical trial of an E75/granulocyte macrophage colony-stimulating...
5.
Woll M, Hueman M, Ryan G, Ioannides C, Henderson C, Sesterhan I, et al.
Int J Oncol
. 2004 Nov;
25(6):1769-80.
PMID: 15547716
The HER2/neu protein is over-expressed in multiple epithelial tumors and the source of immunogenic peptides currently under investigation in vaccine trials in ovarian and breast cancers. We sought to define...
6.
Woll M, Fisher C, Ryan G, Gurney J, Storrer C, Ioannides C, et al.
J Clin Immunol
. 2004 May;
24(4):449-61.
PMID: 15163902
HER2/neu is a proto-oncogene and a member of the epidermal growth factor receptor family of proteins that is overexpressed in numerous types of human cancer. We are currently conducting clinical...